By Patrick Wingrove (Reuters) -One of the largest contract drug manufacturing plants in the U.S. owned by Thermo Fisher ...

Thermo Fisher has outperformed the market with a 420%+ return over the past decade, but its current valuation is high. Check ...

Thermo Fisher Scientific Inc., the world leader in serving science, will showcase its latest innovations enabling the ...

Thermo Fisher Scientific Inc (TMO) stock saw a decline, ending the day at $598.61 which represents a decrease of $-2.31 or -0.38% from the prior close of $600.92. The stock opened at $602.63 and ...

We recently published a list of 10 Best Healthcare Stocks To Buy According to Hedge Funds. In this article, we are going to ...

Shares of Thermo Fisher Scientific Inc. TMO rallied 3.26% to $619.33 Thursday, on what proved to be an all-around positive ...

Shares of Thermo Fisher Scientific Inc. TMO slipped 0.38% to $598.61 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.90% to 5 ...

A complaint against biotechnology company Thermo Fisher Scientific Inc. over how it allocates forfeited 401(k) funds was ...

Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the international CorEvitas ...

Massmutual Trust Co. FSB ADV grew its position in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 2.3% in the 3rd quarter, according to the company in its most recent 13F filing with ...

To provide flexible and innovative solutions for early development challenges commonly faced by biotech and pharmaceutical ...

One of the largest contract drug manufacturing plants in the U.S. owned by Thermo Fisher Scientific over the past 10 years has repeatedly breached rules meant to ensure drugs are free of ...